Jin-Rong Zhou Ph.D.
Assistant Professor, Department of Surgery, Harvard Medical School
Director, Nutrition/Metabolism Laboratory, Beth Israel Deaconess Medical Center
Contact InfoJin-Rong Zhou
Beth Israel Deaconess Medical Center
330 Brookline Avenue
Boston, MA, 02215
Mailstop: Burlington-554B
Phone: 617.632.9222
Fax: 617.632.0275
jrzhou@caregroup.harvard.edu
DF/HCC Program Affiliation
Member, Prostate Cancer Program
Member, Breast Cancer Program

Research Abstract
My primary research interest is to study the effects of dietary bioactive components and herbal ingredients on the prevention and treatment of cancer. The first research area is to explore the role of bioactive components in soybean, tea and certain Chinese herbs in inhibiting the growth and metastasis of prostate cancer by using anatomically relevant animal models, and to elucidate molecular/ cellular mechanisms of action. The second research area is to study the effects of soybean phytochemicals, tea polyphenols and herbal components on the progression of breast cancer. The third research area focuses on the role dietary soy products may play in facilitating the effect of radiation treatment on the cancers of prostate and breast.
Publications
Zhou JR, Yu L, Zerbini LF, Libermann TA, Blackburn GL. Progression to androgen-independent LNCaP human prostate tumors: cellular and molecular alterations. Int J Cancer 2004 Jul 20; 110(6):800-6
PMID: 15170660
Zhou JR, Yu L, Zerbini L, Libermann TA, Blackburn GL. Progression to androgen-independent LNCaP human prostate tumors: Cellular and molecular alterations Int J Cancer 2004 June 1-15; 108:in press
PMID: 0
Zhou JR, Yu L, Zerbini L, Libermann TA, Blackburn GL. Progression to androgen-independent LNCaP human prostate tumors: Cellular and molecular alterations Int J Cancer 2004 June 1-15; 108:in press
PMID: 0
Zhou JR, Yu L, Mai Z, Blackburn GL. Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice Int J Cancer 2004 Jan 1; 108:8-14
PMID: 0
Zhou JR, Yu L, Mai Z, Blackburn GL. Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice Int J Cancer 2004 Jan 1; 108:8-14
PMID: 0
Zhou JR, Yu L, Zhong Y, Blackburn GL. Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice J Nutr 2003 Feb; 133:516-521
PMID: 0
Zhou JR, Yu L, Zhong Y, Blackburn GL. Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice J Nutr 2003 Feb; 133:516-521
PMID: 0
Zhou JR, Yu L, Zhong Y, Nassr RL, Franke AA, Gaston SM, Blackburn GL. Inhibition of orthotopic growth and metastasis of androgen-sensitive human prostate tumors in mice by bioactive soybean components Prostate 2002 Oct; 53:143-153
PMID: 0
Zhou JR, Yu L, Zhong Y, Nassr RL, Franke AA, Gaston SM, Blackburn GL. Inhibition of orthotopic growth and metastasis of androgen-sensitive human prostate tumors in mice by bioactive soybean components Prostate 2002 Oct; 53:143-153
PMID: 0
Zhou JR, Gugger ET, Tanaka T, Guo Y, Blackburn GL, Clinton SK. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J Nutr 1999 Sep; 129(9):1628-35
PMID: 10460196
Mukherjee P, Sotnikov AV, Mangian HJ, Zhou JR, Visek WJ, Clinton SK. Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression. J Natl Cancer Inst 1999 Mar 17; 91(6):512-23
PMID: 10088621
Zhou JR, Mukherjee P, Gugger ET, Tanaka T, Blackburn GL, Clinton SK. Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis. Cancer Res 1998 Nov 15; 58(22):5231-8
PMID: 9823337

不知道你说的那则新闻报道的时候（2002年）是不是教授就不知道了。

网页见：http://www.dfhcc.harvard.edu/membership/member-profile/member/313/0/